Breaking News

TriRx Finalizes Agreement with MSD Sante Animale

Acquires the operations and ownership of its manufacturing site.

By: Contract Pharma

Contract Pharma Staff

TriRx Pharmaceutical Services, a global contract development and manufacturing organization serving the biopharmaceutical market, has finalized an agreement with MSD Sante Animale, a division of Merck & Co. Inc., to acquire the operations and ownership of its manufacturing site located in Segré, France.   Timothy C. Tyson, chairman & CEO of TriRx stated, “We are excited to welcome the Segre team to the TriRx family and to partner with MSD Animal Health to continue to provide important pr...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters